FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.

The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.

Moderator:
- Sherif Guorgui, FIP President, Community Pharmacy Section, So-CEO OnPharm-United, Canada

Panellists:
- Sarah Sorum, Executive Vice President & CEO, Pharmacy Society of Wisconsin, an ASHP state-affiliate, United States
- Marisol Flores Campos, Pharmacovigilance Officer, Punto Seguro, Costa Rica
- Pedro Costa e Silva, Manager - Health Services Business Unit, Associação Nacional das Farmácias (ANF), Portugal
- Omaima Arab, Scientific evaluation expert, Saudi Food and Drug Authority, Saudi Arabia

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

This webinar is the third of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover:
• Current health economics stance on precision medicine applications
• What we know and what we don’t know about precision medicine cost-utility
• How costs may evolve with emerging technologies or trends
• Priorities for future HTA research in this area

At the end of this session, participants will be aware of:
• The impact of precision medicine advancements on health technology assessment
• The economic arguments for and against precision medicine
• International coordination in health technology assessment policies for precision medicine

Moderator:
- Donnacha Fitzgerald, Predoctoral Fellow, The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital - Germany

Panellists:
- Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA
- IÑAKI GUTIERREZ-IBARLUZEA, Board Director and Former President Health Technology Assessment International (HTAi), Spain

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.

Attendees will learn about:

1. The role of pharmacy professionals in point-of-care testing;
2. The importance of providing point-of-care testing services in the screening and management of chronic non-communicable diseases and acute situations;
3. Challenges and opportunities for pharmacists in addressing point-of-care testing services.

Moderator:
- Daragh Connolly, Chair of the FIP Board of Pharmaceutical Practice, Ireland

Panellists:
- Sherif Guorgui, President, FIP Community Pharmacy Section, Canada
- Julien Fonsart, Head of the Clinical Biology laboratory, Saint-Louis Lariboisiere University Hospitals, Greater Paris University Hospitals (APHP), France
- Teresa Torres. General Director of GO FAR ANF, Portugal
- Efi Mantzourani, Reader in Pharmacy Practice / Research and Evaluation Lead in Choose Pharmacy, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University / Primary Care, Digital Health and Care Wales, NHS Wales, UK

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).